BUFFALO GROVE, Ill.--(BUSINESS WIRE)--March 7, 2006--Akorn, Inc. (AMEX:AKN) and Cipla, Ltd., a leading Indian pharmaceutical company located in Mumbai, India, today announced the signing of an exclusive drug manufacturing and supply agreement for an oral anti-infective ANDA drug product.
